latuda

Drug Sumitomo Dainippon Pharma Co., Ltd.
Total Payments
$45,154
Transactions
66
Doctors
6
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $17.64 1 1
2018 $45,136 65 6

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $19,500 7 43.2%
Travel and Lodging $17,583 28 38.9%
Food and Beverage $4,371 28 9.7%
Consulting Fee $3,700 3 8.2%

Top Doctors Receiving Payments for latuda

Doctor Specialty Location Total Records
, MD Pain Medicine Chicago, IL $21,023 19
, MD Psychiatry Cleveland, OH $18,616 22
, MD Psychiatry Minneapolis, MN $3,895 8
, MD Psychiatry Glen Oaks, NY $755.62 7
John Kane Psychiatry New York, NY $748.73 8
, MD Child & Adolescent Psychiatry Glen Oaks, NY $114.64 2

About latuda

latuda is a drug associated with $45,154 in payments to 6 healthcare providers, recorded across 66 transactions in the CMS Open Payments database. The primary manufacturer is Sumitomo Dainippon Pharma Co., Ltd..

Payment data is available from 2018 to 2019. In 2019, $17.64 was paid across 1 transactions to 1 doctors.

The most common payment nature for latuda is "Honoraria" ($19,500, 43.2% of total).